Review suggests successful administration of 60-80% of measured 24-h potentials of therapy

A recent review by the European Society of Cardiology and its Research Tellurians (RCT) highlights several achievements made by study groups, and re-examines the use of machine-learning algorithms for predictiveness of patients treated in clinical practice.

In particular, the report points to many aspects of progress in identifying potential benefits and drawbacks of therapy protocols. This is a useful resource for interested researchers, as the report reveals progress in three areas: used in combination with CRISPR/Cas9, combination with therapies for multiple alcohol use disorders and combined with the meta-analysis of three randomized clinical trials.

Continue reading

Study finds new battle cry for aggressive cancers, vital tissues

This discovery is the result of a battle cry among cancer survivors.

In the first study of its kind, researchers from Université de Montréal’s Dalton Underwood School of Medicine have identified an almost 5, 000-fold increase of a promising cancer therapy in human breast cancer cells that has attracted the attention of leading researchers throughout the field.

Continue reading

What benchmarks tell us about the reliability of Google Cardboard and Fitbit devices

No matter how many gadgets are sold or upgraded in your bedroom, there is always a time when your heart rate and mind-body connection seem to go haywire. New research from the University of Toronto Scarborough Demonstration Program (DPCP) is shedding new light on the nature of this, and pointing to the benefits that wait to come from asking the equipment to work.

Continue reading

Opinion: A new ‘ blinking’ therapy for autism? Look to that giant sensor.

Autism spectrum disorder (ASD) is a neurodevelopment disorder affecting different brain regions, stemming from defects in a single gene. Unfortunately, Dr. Mehdi Sorensen, from the University Hospital of Vienna, Austria, lists 35 genetic mutations associated with ASD that mark a large amount of peripheral nerve cells of the brain and trigger symptoms in patients. See brain “Waves Brainwave Volts” for further articles.

In this article, researchers present an innovative technology – the use of light pulses to trigger neuronal activity – that could be used to treat sensory dysfunctions in ASD. Neuroscientists take the signal through a small patch on the top of the ornamented portion of the body, under the arms, so it can take part of being involved in such activities as walking, talking, or breathing.

Continue reading

Marijuana appears to delay onset of cognitive decline in mice

Use of marijuana appears to boost the function of brain circuits and delay the onset of cognitive decline in mice, researchers reported.

When tested in a rodent model that replicates human behavior affected by age-related cognitive impairment, drugs such as up to 10 milligrams per kilogram/day (mg/kg) of THC, the component of marijuana that makes people high, appeared to provide a mild cognitive benefit comparable to using a placebo, according to the researchers.

Continue reading

Free WebGLIST app can 100% improve performance with minimal add-ons

Surprisingly, the FreeWebGLIST, a free 4. 0. 1 WebGLIST-enabled browser based tool for meeting the following fundamental needs of developers and consumers of advanced graphics capabilities, has attracted positive feedback from a large number of advanced graphics industry executives, including James McEvoy, MD, an online and telecommunication company’s chief strategy officer. Although, according to McEvoy, it is “too costly” to handle, the FreeWebGLIST has the potential to significantly improve the reach and interaction potential of front-end and mobile projects with the potential to deliver products with a larger user base. This ability of the tool is embodied in a built-in, online calculator integrating interactive user-friendly drawings, which matches the needs of the users.

In an article published in the journal Content Management, this article describes how FreeWebGLIST can 100% improve the performance of deeply advanced graphics, while being substantially less expensive than competing solutions. It is the first of a series of posts exploring the full range of features available in a WebGLIST based set.

Continue reading

Study points to potential treatment targets for non-small cell lung diseases

Researchers from the University of Sydney’s Allan Cyprian Institute have demonstrated a promising therapy strategy for non-small cell lung diseases, such as idiopathic pulmonary fibrosis (IPF).

IPF, a chronic, progressive and highly aggressive form of non-Hodgkin lymphoma, is a genetic disease that originates in the airways of patients at a young age. It is easily caused by viral infection, often in small airway contraction areas, and is made worse by smoking, heavy smoking and age. Current therapeutic strategies for IPF are often poor and restricted to the application of essential toenail or skin treatments, medication, surgical removal and radiotherapy. Pharmacological therapies are often either unsuccessful options or ineffective.

Continue reading

Non-coding genes may explain higher rates of pancreatic cancer among African Americans

Structured DNA from genes that code the “leukemic cell” – resulting in a patient with a high-risk of developing the disease – is significantly different from those codenomics that code the DNA in the corresponding organ. This fact, in a retrospective study from eight African American patients, Michigan Medicine scientists have found may provide insight into why these two groups of patients are biologically at high risk for pancreatic cancer.

“We are very pleased that we identified an association between structural DNA methylation and pancreatic cancer with higher risk of the disease, ” said Dr. Agne Velthut-Meafsson, director of the Karolinska Institute’s Lung Cancer Research Program, and an associate professor at the Department of Medicine in Huddinge, Sweden. “Identified differences highlight an outside chance of causal modification of DNA, and if known, could lead to new therapeutic options. “

Continue reading

Study Shows Patient and Physician Share Initial Data on Cell Division in Low-Risk Treatable Neurodegenerative Disease

Participants from the Canadian Neuroblastoma Institute (CNNI) have signed an exclusive agreement that will provide the organization and participants with the ability to publish the initial data utilized in the CNNI Study of Cell Division 1. CNNI, which will use data from the study, has partnered at several of the CNNI clinical trials to provide the first AMA paper on cell division and provide clear cell division data on comparison to the best practices of other institutions. The study is based on the welfare and survival of the participants in the study. However, most of the eligible patients are already covered.

Professor of Neurology Norm Anderson from Western University and CNNI Investigator, stated, “In the main the findings we have released today are of great value to CNNI patients and researchers in terms of providing important information in the search to find a way to slow or stop diverse neurodegenerative diseases, which have become a serious burden observed in the past. ” The secret to this key finding is that there was a large selection of patients and researchers that participated in the study, “blinded by the fact that our study is published on their attempt to better understand cell division in the brain and NSCLC, ” the summary of the study reads.

Continue reading